McConnell’s hemp ban risks wiping out most U.S. hemp-derived products, while MSOs pin hopes on Schedule III rescheduling that ...

First MHRA-approved low-dose atropine eye drop to slow the progression of myopia (short-sightedness) in children aged 3-14 years with a progression rate of 0.5 D or more per year and a severity of -0.

EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution Paris, France (6 November 2025) – EssilorLuxottica today ...

Secondary techniques are needed to address macular holes in patients with myopia, according to a speaker at OSN New York ...

Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...

How severe should myopia be in a pediatric patient to justify starting treatment, and when is it appropriate to begin tapering that treatment.

Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...

UAB School of Optometry professor is joining a national network study to research myopia prevention in children. Myopia, ...

Having just taken part in the China International Import Expo for the fourth consecutive year, Geneva-headquartered eye care ...

Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025 ...

From cutting-edge vision correction (including LASIK) to next-generation cataract surgery, here’s your insider guide to ...